Current and future use of favipiravir in patients with COVID-19

There are experimental and clinical data regarding the activity of favipiravir against the SARS-CoV-2 virus. The is evidence of significant variability in pharmacokinetics and associated achievement of the required inhibitory concentration of the drug. The evidence base for the effectiveness of use...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Matveev (Author), Yu. Yu. Kiselev (Author), D. A. Sychev (Author)
Format: Book
Published: Izdatelstvo OKI, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available